Biomaxima (WAR:BMX) E10: zł1.54 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:BMX Biomaxima SA WAR:BMX
51 GF Score
Price zł9.77
GF Value zł15.43
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Biomaxima E10?

Biomaxima WAR:BMX +4.38% 51 E10 is zł1.54 as of Mar. 2026. GuruFocus rates WAR:BMX with a GF Score™ of 51/100 and a GF Value™ of zł15.43 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biomaxima's adjusted earnings per share data for the three months ended in Mar. 2026 was zł0.080. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is zł1.54 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Biomaxima's average E10 Growth Rate was -1.30% per year. During the past 3 years, the average E10 Growth Rate was 1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biomaxima was 39.60% per year. The lowest was 1.40% per year. And the median was 20.50% per year.

As of today (2026-07-21), Biomaxima's current stock price is zł9.77. Biomaxima's E10 for the quarter that ended in Mar. 2026 was zł1.54. Biomaxima's Shiller PE Ratio of today is 6.34.

During the past 13 years, the highest Shiller PE Ratio of Biomaxima was 87.35. The lowest was 6.04. And the median was 11.42.


Biomaxima  (WAR:BMX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biomaxima's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=9.77/1.54
=6.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Biomaxima was 87.35. The lowest was 6.04. And the median was 11.42.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biomaxima E10 Related Terms


Biomaxima E10 Historical Data

* Premium members only.

The historical data trend for Biomaxima's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomaxima E10 Chart

Biomaxima Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.57 1.45 1.49 1.55 1.51

Biomaxima Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.56 1.54 1.52 1.51 1.54

WAR:BMX vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, Biomaxima's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomaxima Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomaxima's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biomaxima's Shiller PE Ratio falls into.


WAR:BMX
51GF Score
Biomaxima SA WAR:BMX
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biomaxima E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biomaxima's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.08/163.0700*163.0700
=0.080

Current CPI (Mar. 2026) = 163.0700.

Biomaxima Quarterly Data

per share eps CPI Adj_EPS
201606 0.065 99.552 0.106
201609 0.061 99.064 0.100
201612 0.066 100.366 0.107
201703 0.085 101.018 0.137
201706 0.031 101.180 0.050
201709 0.104 101.343 0.167
201712 0.110 102.564 0.175
201803 0.067 102.564 0.107
201806 0.138 103.378 0.218
201809 -0.157 103.378 -0.248
201812 -0.178 103.785 -0.280
201903 -0.047 104.274 -0.074
201906 -0.032 105.983 -0.049
201909 -0.016 105.983 -0.025
201912 0.091 107.123 0.139
202003 -0.010 109.076 -0.015
202006 0.710 109.402 1.058
202009 0.270 109.320 0.403
202012 0.840 109.565 1.250
202103 1.400 112.658 2.026
202106 0.140 113.960 0.200
202109 0.300 115.588 0.423
202112 0.450 119.088 0.616
202203 5.430 125.031 7.082
202206 0.790 131.705 0.978
202209 0.210 135.531 0.253
202212 0.070 139.113 0.082
202303 0.110 145.950 0.123
202306 0.090 147.009 0.100
202309 -0.090 146.113 -0.100
202312 0.020 147.741 0.022
202403 0.060 149.044 0.066
202406 -0.100 150.997 -0.108
202409 -0.060 153.439 -0.064
202412 0.230 154.660 0.243
202503 0.140 157.021 0.145
202506 -0.140 157.509 -0.145
202509 -0.070 158.000 -0.072
202512 0.110 158.320 0.113
202603 0.080 163.070 0.080

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of zł1.54 mean?
Biomaxima (WAR:BMX) has a E10 of zł1.54 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Biomaxima and its competitors.
Is Biomaxima's E10 too high?
Biomaxima's current E10 is zł1.54. Overall, Biomaxima has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biomaxima's E10 compare to TMO and DHR?
Biomaxima's E10 of zł1.54 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Biomaxima and its competitors. Biomaxima's current E10 is zł1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomaxima stock overvalued right now?
Based on GuruFocus' analysis, Biomaxima (WAR:BMX) is currently considered Possible Value Trap. The stock's GF Value™ is zł15.43, compared to a current price of zł9.77 — trading 36.7% below its estimated fair value. The current E10 is zł1.54. Biomaxima's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Biomaxima (WAR:BMX), the current E10 is zł1.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biomaxima (WAR:BMX) Overvalued in 2026?

Based on GuruFocus' analysis, Biomaxima stock appears to be undervalued. The current stock price of zł9.77 is trading 36.7% below its estimated GF Value™ of zł15.43. GuruFocus considers Biomaxima to be Possible Value Trap.

Key valuation signals for WAR:BMX:

  • E10: zł1.54
  • GF Value™: zł15.43 vs. price of zł9.77 (36.7% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the WAR:BMX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biomaxima Business Description

Address 5 Vetterow Street, Lublin, POL, 20-277
BioMaxima SA is a Polish company operating in the market of laboratory diagnostics. It is a manufacturer of microbiological substrates as well as a wide range of reagents and diagnostic equipment. The company is also a distributor of products of recognized multinational diagnostic companies such as: Accelerate Diagnostics, Nova Biomedical, PHC Group, Technoclone, Kabe and Biolog.
51GF Score

Get the complete analysis for WAR:BMX

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł9.77
Price
zł15.43
GF Value